Patent Document ID: 10102927
Application ID: 14483921
Patent Flag: 1

Claim One:
1. A method for conducting genetic testing, comprising: creating a biomarker entry in a biomarker script database; encoding a list of single nucleotide polymorphisms and mutation definitions corresponding to the biomarker entry in the biomarker script database, wherein the list of single nucleotide polymorphisms and mutation definitions is associated with the biomarker entry; encoding an interpretations list in the biomarker database, the interpretations list associated with the biomarker entry, wherein the interpretations list provides a risk factor for a disease based on the mutations in the list of single nucleotide polymorphisms and mutation definitions; scanning the genome or portion of a genome of a patient with a remote client containing the interpretations list to determine the presence of the mutation definitions, wherein the genome or portion of a genome is stored in a storage area network collocated with the remote client; and providing the risk factor corresponding to the determination of the presence of the mutation definitions; wherein the risk factor is used in diagnosis of at least one condition or disease; and wherein the step of scanning a genome or portion of a genome of a patient to determine the presence of the mutation definitions comprises: (a) retrieving the list of single nucleotide polymorphisms and mutation definitions in the biomarker script database corresponding to the biomarker identifier; (b) scanning the genome or portion of a genome of the patient for each of the mutation definitions; and (c) determining a number of mutations present in the genome or portion of a genome.